PedAM
Pediatric Disease Annotations & Medicines
| Disease | diarrhea |
| Phenotype | C0206754|neuroendocrine tumor |
| Sentences | 5 |
| PubMedID- 23432909 | Initially described in 1955 [1], zollinger–ellison syndrome is characterized by multiple and recurrent peptic ulcers and persistent diarrhea that result from gastrin-secreting neuroendocrine tumors (gastrinomas) of the gastrointestinal tract [2]. |
| PubMedID- 23119007 | In summary, somatostatin analogs (including octreotide and lanreotide) have been indicated for the relief of the symptoms of flushing, diarrhea, and wheezing associated with secretory neuroendocrine tumors (nets). |
| PubMedID- 23675671 | Ondansetron for diarrhea associated with neuroendocrine tumors. |
| PubMedID- 22628056 | Background: for decades, somatostatin analogs (including octreotide and lanreotide) have been indicated for relief of the symptoms of flushing, diarrhea, and wheezing associated with secretory neuroendocrine tumors (nets). |
| PubMedID- 25727756 | Patients with nonresectable metastatic neuroendocrine tumors (nets) experience symptoms of hormone hypersecretion including diarrhea, flushing, and bronchoconstriction, which can interfere with quality of life [anthony and vinik (2011) pancreas, 40:987]. |
Page: 1